Showing 21-40 of 412 results
New Approaches to Neuroblastoma Therapy (NANT) Consortium Member
Funded: 07-01-2017 through 06-30-2018
Funding Type: Consortium Research Grant
Institution Location: Seattle, WA
Institution: Seattle Children's Hospital affiliated with Fred Hutchinson Cancer Research Center, University of Washington

This institution is a member of a research consortium which is being funded by St. Baldrick's: New Approaches to Neuroblastoma Therapy (NANT) Consortium. For a description of this project, see the consortium grant made to the lead institution: Children's Hospital Los Angeles, Los Angeles, CA.

Treehouse Childhood Cancer Initiative Member
Funded: 07-01-2016 through 06-30-2018
Funding Type: Consortium Research Grant
Institution Location: Vancouver, BC
Institution: British Columbia Cancer Agency affiliated with British Columbia Children's Hospital, The University of British Columbia

This institution is a member of a research consortium which is being funded by St. Baldrick's: Treehouse Childhood Cancer Initiative. For a description of this project, see the consortium grant made to the lead institution: University of California Santa Cruz, Santa Cruz, CA.

Treehouse Childhood Cancer Initiative Member
Funded: 07-01-2016 through 06-30-2018
Funding Type: Consortium Research Grant
Institution Location: Vancouver, BC
Institution: British Columbia Children's Hospital affiliated with British Columbia Cancer Agency, The University of British Columbia

This institution is a member of a research consortium which is being funded by St. Baldrick's: Treehouse Childhood Cancer Initiative. For a description of this project, see the consortium grant made to the lead institution: University of California Santa Cruz, Santa Cruz, CA.

Treehouse Childhood Cancer Initiative Member
Funded: 07-01-2016 through 06-30-2018
Funding Type: Consortium Research Grant
Institution Location: Orange, CA
Institution: Children's Hospital of Orange County

This institution is a member of a research consortium which is being funded by St. Baldrick's: Treehouse Childhood Cancer Initiative. For a description of this project, see the consortium grant made to the lead institution: University of California Santa Cruz, Santa Cruz, CA.

Treehouse Childhood Cancer Initiative Member
Funded: 07-01-2016 through 06-30-2018
Funding Type: Consortium Research Grant
Institution Location: Palo Alto, CA
Institution: Stanford University affiliated with Lucile Packard Children’s Hospital

This institution is a member of a research consortium which is being funded by St. Baldrick's: Treehouse Childhood Cancer Initiative. For a description of this project, see the consortium grant made to the lead institution: University of California Santa Cruz, Santa Cruz, CA.

Treehouse Childhood Cancer Initiative Member
Funded: 07-01-2016 through 06-30-2018
Funding Type: Consortium Research Grant
Institution Location: San Francisco, CA
Institution: University of California, San Francisco affiliated with UCSF Benioff Children's Hospital

This institution is a member of a research consortium which is being funded by St. Baldrick's: Treehouse Childhood Cancer Initiative. For a description of this project, see the consortium grant made to the lead institution: University of California Santa Cruz, Santa Cruz, CA.

Pediatric LEukemiA Precision-based Therapy (LEAP) Consortium Member
Funded: 07-01-2016 through 06-30-2018
Funding Type: Consortium Research Grant
Institution Location: San Francisco, CA
Institution: University of California, San Francisco affiliated with UCSF Benioff Children's Hospital

This institution is a member of a research consortium which is being funded by St. Baldrick's: Pediatric LEukemiA Precision-based Therapy (LEAP) Consortium. For a description of this project, see the consortium grant made to the lead institution: Dana-Farber Cancer Institute, Boston, MA.

Treehouse Childhood Cancer Initiative
Funded: 07-01-2016 through 06-30-2018
Funding Type: Consortium Research Grant
Institution Location: Santa Cruz, CA
Institution: University of California, Santa Cruz

Cancer is a genetic disease caused by errors in the genomic content of tumor cells. This consortium shares, in real-time, pediatric cancer data generated by genomic studies across the world, uniting data on a variety of cancer types from diverse sources into a compendium of unprecedented scale. The consortium uses the collected data to analyze each child's cancer data against both childhood and adult patient cohorts across all types of cancer, so that this information can be used for clinical decision-making. The research team has evidence that this cross-cancer analysis can identify situations where a drug developed for another indication may work in a pediatric cancer, providing new treatment avenues and new hope to children with cancer and their families. Funds administered by University of California Santa Cruz.

Pediatric LEukemiA Precision-based Therapy (LEAP) Consortium Member
Funded: 07-01-2016 through 06-30-2018
Funding Type: Consortium Research Grant
Institution Location: Denver, CO
Institution: University of Colorado affiliated with Children's Hospital Colorado

This institution is a member of a research consortium which is being funded by St. Baldrick's: Pediatric LEukemiA Precision-based Therapy (LEAP) Consortium. For a description of this project, see the consortium grant made to the lead institution: Dana-Farber Cancer Institute, Boston, MA.

Pediatric LEukemiA Precision-based Therapy (LEAP) Consortium Member
Funded: 07-01-2016 through 06-30-2018
Funding Type: Consortium Research Grant
Institution Location: Chicago, IL
Institution: The University of Chicago affiliated with Comer Children's Hospital

This institution is a member of a research consortium which is being funded by St. Baldrick's: Pediatric LEukemiA Precision-based Therapy (LEAP) Consortium. For a description of this project, see the consortium grant made to the lead institution: Dana-Farber Cancer Institute, Boston, MA.

Pediatric LEukemiA Precision-based Therapy (LEAP) Consortium
Funded: 07-01-2016 through 06-30-2018
Funding Type: Consortium Research Grant
Institution Location: Boston, MA
Institution: Dana-Farber Cancer Institute affiliated with Boston Children's Hospital, Harvard Medical School

This consortium is conducting the first multi-institutional, genomics-based precision medicine trial for children with relapsed, refractory, and very high-risk leukemias. They are deploying new technologies to sequence all currently known cancer-promoting genes in an individual child’s leukemia. Next, guided by a multi-disciplinary group of leukemia experts, they will make treatment recommendations based upon the genomic findings in the child’s leukemia and the availability of a relevant targeted drugs for children. Results from this project will define the types and frequency of specific mutations in children with relapsed/refractory leukemia, and assess the impact of the treatment recommendations on their clinical care. The consortium will also perform laboratory-based studies to determine the response to therapy in lab models derived from the patient’s leukemia cells, to identify new drug targets for these children. Data generated in this proposal will inform future genomically-based targeted therapy trials for children with leukemia with the long-term goal of precise, safe, and more efficacious therapies for children with these diseases. Funds administered by Dana-Farber Cancer Institute.

Pediatric LEukemiA Precision-based Therapy (LEAP) Consortium Member
Funded: 07-01-2016 through 06-30-2018
Funding Type: Consortium Research Grant
Institution Location: Baltimore, MD
Institution: Johns Hopkins University School of Medicine affiliated with Johns Hopkins Children's Center

This institution is a member of a research consortium which is being funded by St. Baldrick's: Pediatric LEukemiA Precision-based Therapy (LEAP) Consortium. For a description of this project, see the consortium grant made to the lead institution: Dana-Farber Cancer Institute, Boston, MA.

Treehouse Childhood Cancer Initiative Member
Funded: 07-01-2016 through 06-30-2018
Funding Type: Consortium Research Grant
Institution Location: Ann Arbor, MI
Institution: University of Michigan affiliated with C.S. Mott Children’s Hospital

This institution is a member of a research consortium which is being funded by St. Baldrick's: Treehouse Childhood Cancer Initiative. For a description of this project, see the consortium grant made to the lead institution: University of California Santa Cruz, Santa Cruz, CA.

Pediatric LEukemiA Precision-based Therapy (LEAP) Consortium Member
Funded: 07-01-2016 through 06-30-2018
Funding Type: Consortium Research Grant
Institution Location: Bronx, NY
Institution: Children's Hospital at Montefiore affiliated with Albert Einstein College of Medicine of Yeshiva University, Montefiore Medical Center

This institution is a member of a research consortium which is being funded by St. Baldrick's: Pediatric LEukemiA Precision-based Therapy (LEAP) Consortium. For a description of this project, see the consortium grant made to the lead institution: Dana-Farber Cancer Institute, Boston, MA.

Pediatric LEukemiA Precision-based Therapy (LEAP) Consortium Member
Funded: 07-01-2016 through 06-30-2018
Funding Type: Consortium Research Grant
Institution Location: New York, NY
Institution: Columbia University Medical Center affiliated with Morgan Stanley Children’s Hospital, New York-Presbyterian

This institution is a member of a research consortium which is being funded by St. Baldrick's: Pediatric LEukemiA Precision-based Therapy (LEAP) Consortium. For a description of this project, see the consortium grant made to the lead institution: Dana-Farber Cancer Institute, Boston, MA.

Treehouse Childhood Cancer Initiative Member
Funded: 07-01-2016 through 06-30-2018
Funding Type: Consortium Research Grant
Institution Location: Philadelphia, PA
Institution: The Children's Hospital of Philadelphia affiliated with University of Pennsylvania

This institution is a member of a research consortium which is being funded by St. Baldrick's: Treehouse Childhood Cancer Initiative. For a description of this project, see the consortium grant made to the lead institution: University of California Santa Cruz, Santa Cruz, CA.

Pediatric LEukemiA Precision-based Therapy (LEAP) Consortium Member
Funded: 07-01-2016 through 06-30-2018
Funding Type: Consortium Research Grant
Institution Location: Philadelphia, PA
Institution: The Children's Hospital of Philadelphia affiliated with University of Pennsylvania

This institution is a member of a research consortium which is being funded by St. Baldrick's: Pediatric LEukemiA Precision-based Therapy (LEAP) Consortium. For a description of this project, see the consortium grant made to the lead institution: Dana-Farber Cancer Institute, Boston, MA.

Pediatric LEukemiA Precision-based Therapy (LEAP) Consortium Member
Funded: 07-01-2016 through 06-30-2018
Funding Type: Consortium Research Grant
Institution Location: Seattle, WA
Institution: Seattle Children's Hospital affiliated with Fred Hutchinson Cancer Research Center, University of Washington

This institution is a member of a research consortium which is being funded by St. Baldrick's: Pediatric LEukemiA Precision-based Therapy (LEAP) Consortium. For a description of this project, see the consortium grant made to the lead institution: Dana-Farber Cancer Institute, Boston, MA.

Pediatric Blood & Marrow Transplant Consortium Member
Funded: 07-01-2015 through 06-30-2018
Funding Type: Consortium Research Grant
Institution Location: Calgary, AB
Institution: Alberta Children's Hospital affiliated with University of Calgary

This institution is a member of a research consortium which is being funded by St. Baldrick's: Pediatric Blood & Marrow Transplant Consortium. For a description of this project, see the consortium grant made to the lead institution: the National Marrow Donor Program, Minneapolis, MN.

Late Effects After High Risk Neuroblastoma – The LEAHRN Study Member
Funded: 07-01-2015 through 06-30-2018
Funding Type: Consortium Research Grant
Institution Location: Birmingham, AL
Institution: University of Alabama at Birmingham affiliated with Children's of Alabama

This institution is a member of a research consortium which is being funded by St. Baldrick's: Late Effects After High Risk Neuroblastoma – The LEAHRN Study. For a description of this project, see the consortium grant made to the lead institution: University of Chicago, Chicago, IL